The critical path
The Population Council is an international nonprofit, nongovernmental organization that conducts biomedical, social science, and public health research on HIV and AIDS; poverty, gender and youth; and reproductive health (RH). Our work cuts across disciplines, geographies, and the public and private sectors. The Population Council develops and tests the effectiveness and acceptability of new and improved health technologies, including contraceptives and microbicides, which are designed to benefit women and men in developing countries. Our work includes user's perspectives throughout the development and introduction process. In addition, we encourage licensing, registration, manufacturing, and distribution of contraceptive and other RH technologies developed by the Council.
Council's work on product development
The Population Council has developed and licensed some of the most widely used long-acting, reversible contraceptives in the world. Our work includes basic research directed toward fundamental understanding of biology and disease processes, providing the foundation for product development, as well as translational research which employs novel techniques and tools in the lab, and innovative approaches in field programs to ensure that our scientific discoveries translate into improving the lives of women and men around the globe.
As a product developer we know what is required to take an innovation to a viable product. Product developers must negotiate scientific and technical dimensions along the critical path from innovation to commercial product. Whether working with drugs, devices, or biologics-or some combination thereof-our experience suggests that this pathway encompasses scientific, technical, programmatic and policy dimensions. 
